Table 4 Anticancer treatment in the patient with organ dysfunction and advanced NSCLC
DysfunctionProposed approach practical approach
Renal failureCisplatin and mitomycin are contra-indicated. Consider carboplatin (prescribed according to renal clearance).
Liver diseasesCisplatin-based with drugs nonmetabolised by the liver.
Bone marrowChemotherapy with reduced dosages and with active haematological support.
Cardiac failureCisplatin, taxans and ifosfamide are contra-indicated. Consider nonplatinum-based chemotherapy.
PolyneuropathyCisplatin, vinca-alcaloids and taxans are contra-indicated. Consider regimens with ifosfamide, gemcitabine, carboplatin or/and etoposide or TKI.
HypoacousiaPlatinum derivatives are contra-indicated. Consider nonplatinum-based chemotherapy.